TRIM29 negatively regulates p53 via inhibition of Tip60

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 6, 2011, Pages 1245-1253

  Sho, Takuya ^a   Tsukiyama, Tadasuke ^a   Sato, Tomonobu ^a   Kondo, Takeshi ^a   Cheng, Jun ^b   Saku, Takashi ^b   Asaka, Masahiro ^a   Hatakeyama, Shigetsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Ataxia telangiectasia; P53; Tip60; TRIM29; Ubiquitin

Indexed keywords

ACYLTRANSFERASE; LYSINE; ONCOPROTEIN; PROTEIN P53; PROTEIN TRIM29; TAT INTERACTIVE PROTEIN 60; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ACETYLATION; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYSINE; MICE; NIH 3T3 CELLS; PROTEIN BINDING; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

ATAXIA TELANGIECTASIA;

EID: 79955658113     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.03.018     Document Type: Article

References (41)

1. Kapp L.N., Painter R.B., Yu L.C., van Loon N., Richard C.W., James M.R., Cox D.R., Murnane J.P. Cloning of a candidate gene for ataxia-telangiectasia group D. Am. J. Hum. Genet. 1992, 51:45-54.
2. Brzoska P.M., Chen H., Zhu Y., Levin N.A., Disatnik M.H., Mochly-Rosen D., Murnane J.P., Christman M.F. The product of the ataxia-telangiectasia group D complementing gene. ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl. Acad. Sci. USA 1995, 92:7824-7828.
3. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
4. Quaderi N.A., Schweiger S., Gaudenz K., Franco B., Rugarli E.I., Berger W., Feldman G.J., Volta M., Andolfi G., Gilgenkrantz S., Marion R.W., Hennekam R.C., Opitz J.M., Muenke M., Ropers H.H., Ballabio A. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet. 1997, 17:285-291.
5. Jensen K., Shiels C., Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001, 20:7223-7233.
6. Remboutsika E., Lutz Y., Gansmuller A., Vonesch J.L., Losson R., Chambon P. The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. J. Cell Sci. 1999, 112(Pt 11):1671-1683.
7. Dho S.H., Kwon K.S. The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J. Biol. Chem. 2003, 278:31902-31908.
8. Kamine J., Elangovan B., Subramanian T., Coleman D., Chinnadurai G. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 1996, 216:357-366.
9. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000, 102:463-473.
10. Sapountzi V., Logan I.R., Robson C.N. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 2006, 38:1496-1509.
11. Squatrito M., Gorrini C., Amati B. Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol. 2006, 16:433-442.
12. Gaughan L., Brady M.E., Cook S., Neal D.E., Robson C.N. Tip60 is a co-activator specific for class I nuclear hormone receptors. J. Biol. Chem. 2001, 276:46841-46848.
13. Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M., Livingston D.M., Amati B. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 2003, 4:575-580.
14. Xiao H., Chung J., Kao H.Y., Yang Y.C. Tip60 is a co-repressor for STAT3. J. Biol. Chem. 2003, 278:11197-11204.
15. Kim J.H., Kim B., Cai L., Choi H.J., Ohgi K.A., Tran C., Chen C., Chung C.H., Huber O., Rose D.W., Sawyers C.L., Rosenfeld M.G., Baek S.H. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005, 434:921-926.
16. Taubert S., Gorrini C., Frank S.R., Parisi T., Fuchs M., Chan H.M., Livingston D.M., Amati B. E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol. Cell. Biol. 2004, 24:4546-4556.
17. Legube G., Linares L.K., Tyteca S., Caron C., Scheffner M., Chevillard-Briet M., Trouche D. Role of the histone acetyl transferase Tip60 in the p53 pathway. J. Biol. Chem. 2004, 279:44825-44833.
18. Legube G., Linares L.K., Lemercier C., Scheffner M., Khochbin S., Trouche D. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 2002, 21:1704-1712.
19. Sykes S.M., Mellert H.S., Holbert M.A., Li K., Marmorstein R., Lane W.S., McMahon S.B. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 2006, 24:841-851.
20. Tang Y., Luo J., Zhang W., Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 2006, 24:827-839.
21. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000, 7:1063-1066.
22. Deissler H., Kafka A., Schuster E., Sauer G., Kreienberg R., Zeillinger R. Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response. Oncol. Rep. 2004, 11:1281-1286.
23. Hosoi Y., Kapp L.N., Murnane J.P., Matsumoto Y., Enomoto A., Ono T., Miyagawa K. Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene. ATDC Biochem. Biophys. Res. Commun. 2006, 348:728-734.
24. Hawthorn L., Stein L., Panzarella J., Loewen G.M., Baumann H. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer 2006, 53:129-142.
25. Dyrskjot L., Kruhoffer M., Thykjaer T., Marcussen N., Jensen J.L., Moller K., Orntoft T.F. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 2004, 64:4040-4048.
26. Glebov O.K., Rodriguez L.M., Soballe P., DeNobile J., Cliatt J., Nakahara K., Kirsch I.R. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2253-2262.
27. Ohmachi T., Tanaka F., Mimori K., Inoue H., Yanaga K., Mori M. Clinical significance of TROP2 expression in colorectal cancer. Clin. Cancer Res. 2006, 12:3057-3063.
28. Santin A.D., Zhan F., Bellone S., Palmieri M., Cane S., Bignotti E., Anfossi S., Gokden M., Dunn D., Roman J.J., O'Brien T.J., Tian E., Cannon M.J., Shaughnessy J., Pecorelli S. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int. J. Cancer 2004, 112:14-25.
29. Kosaka Y., Inoue H., Ohmachi T., Yokoe T., Matsumoto T., Mimori K., Tanaka F., Watanabe M., Mori M. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann. Surg. Oncol. 2007, 14:2543-2549.
30. Wang L., Heidt D.G., Lee C.J., Yang H., Logsdon C.D., Zhang L., Fearon E.R., Ljungman M., Simeone D.M. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 2009, 15:207-219.
31. Mutter G.L., Baak J.P., Fitzgerald J.T., Gray R., Neuberg D., Kust G.A., Gentleman R., Gullans S.R., Wei L.J., Wilcox M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol. Oncol. 2001, 83:177-185.
32. Zhan F., Hardin J., Kordsmeier B., Bumm K., Zheng M., Tian E., Sanderson R., Yang Y., Wilson C., Zangari M., Anaissie E., Morris C., Muwalla F., van Rhee F., Fassas A., Crowley J., Tricot G., Barlogie B., Shaughnessy J. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002, 99:1745-1757.
33. Smith A.P., Hoek K., Becker D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol. Ther. 2005, 4:1018-1029.
34. Nacht M., Ferguson A.T., Zhang W., Petroziello J.M., Cook B.P., Gao Y.H., Maguire S., Riley D., Coppola G., Landes G.M., Madden S.L., Sukumar S. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 1999, 59:5464-5470.
35. Zhang L., Duan C.J., Binkley C., Li G., Uhler M.D., Logsdon C.D., Simeone D.M. A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol. Cell. Biol. 2004, 24:2169-2180.
36. LaTulippe E., Satagopan J., Smith A., Scher H., Scardino P., Reuter V., Gerald W.L. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002, 62:4499-4506.
37. Luo J., Duggan D.J., Chen Y., Sauvageot J., Ewing C.M., Bittner M.L., Trent J.M., Isaacs W.B. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 2001, 61:4683-4688.
38. Yu Y.P., Landsittel D., Jing L., Nelson J., Ren B., Liu L., McDonald C., Thomas R., Dhir R., Finkelstein S., Michalopoulos G., Becich M., Luo J.H. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 2004, 22:2790-2799.
39. Tyteca S., Legube G., Trouche D. To die or not to die: a HAT trick. Mol. Cell 2006, 24:807-808.
40. Yuan Z., Villagra A., Peng L., Coppola D., Glozak M., Sotomayor E.M., Chen J., Lane W.S., Seto E. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol. Cell. Biol. 2010, 30:3004-3015.
41. Bertrand-Vallery V., Belot N., Dieu M., Delaive E., Ninane N., Demazy C., Raes M., Salmon M., Poumay Y., Debacq-Chainiaux F., Toussaint O. Proteomic profiling of human keratinocytes undergoing UVB-induced alternative differentiation reveals TRIpartite motif protein 29 as a survival factor. PLoS One 2010, 5:e10462.